CY1114452T1 - Ενωσεις πυρρολιου - Google Patents

Ενωσεις πυρρολιου

Info

Publication number
CY1114452T1
CY1114452T1 CY20131100636T CY131100636T CY1114452T1 CY 1114452 T1 CY1114452 T1 CY 1114452T1 CY 20131100636 T CY20131100636 T CY 20131100636T CY 131100636 T CY131100636 T CY 131100636T CY 1114452 T1 CY1114452 T1 CY 1114452T1
Authority
CY
Cyprus
Prior art keywords
halogen
optionally substituted
alkyl group
hydrogen atom
atom
Prior art date
Application number
CY20131100636T
Other languages
Greek (el)
English (en)
Inventor
Haruyuki Nishida
Yasuyoshi Arikawa
Ikuo Fujimori
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41508823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1114452(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of CY1114452T1 publication Critical patent/CY1114452T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY20131100636T 2008-08-27 2013-07-26 Ενωσεις πυρρολιου CY1114452T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008218851 2008-08-27
JP2008269099 2008-10-17
EP09788053.8A EP2318390B1 (en) 2008-08-27 2009-08-26 Pyrrole compounds

Publications (1)

Publication Number Publication Date
CY1114452T1 true CY1114452T1 (el) 2016-10-05

Family

ID=41508823

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100636T CY1114452T1 (el) 2008-08-27 2013-07-26 Ενωσεις πυρρολιου

Country Status (38)

Country Link
US (3) US8969387B2 (enExample)
EP (1) EP2318390B1 (enExample)
JP (1) JP5638515B2 (enExample)
KR (1) KR101629181B1 (enExample)
CN (1) CN102197033B (enExample)
AR (1) AR073136A1 (enExample)
AU (1) AU2009284867B2 (enExample)
BR (1) BRPI0917705A2 (enExample)
CA (1) CA2735162C (enExample)
CL (1) CL2011000402A1 (enExample)
CO (1) CO6321166A2 (enExample)
CR (1) CR20110169A (enExample)
CY (1) CY1114452T1 (enExample)
DK (1) DK2318390T3 (enExample)
DO (1) DOP2011000061A (enExample)
EA (1) EA019741B1 (enExample)
EC (1) ECSP11010912A (enExample)
ES (1) ES2423289T3 (enExample)
GE (1) GEP20135786B (enExample)
HR (1) HRP20130653T1 (enExample)
IL (1) IL211335A (enExample)
JO (1) JO2871B1 (enExample)
MA (1) MA32647B1 (enExample)
ME (1) ME01598B (enExample)
MX (1) MX2011001955A (enExample)
MY (1) MY152008A (enExample)
NZ (1) NZ591793A (enExample)
PE (2) PE20141174A1 (enExample)
PL (1) PL2318390T3 (enExample)
PT (1) PT2318390E (enExample)
RS (1) RS52872B (enExample)
SI (1) SI2318390T1 (enExample)
SM (1) SMT201300085B (enExample)
TW (1) TWI473798B (enExample)
UA (1) UA105185C2 (enExample)
UY (1) UY32074A (enExample)
WO (1) WO2010024451A1 (enExample)
ZA (1) ZA201101774B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ591793A (en) 2008-08-27 2012-11-30 Takeda Pharmaceutical Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds
US20110229879A1 (en) * 2010-03-19 2011-09-22 University Of Rochester Methods and compositions for nuclear staining
CN102452979B (zh) * 2010-11-03 2015-04-01 天津药明康德新药开发有限公司 5-氟-3-吡啶磺酰氯的合成方法
CN102863371B (zh) * 2011-07-06 2016-04-13 中国科学院上海有机化学研究所 氟代二氢吡咯或氟代吡咯
WO2013119800A1 (en) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
NZ703528A (en) 2012-06-27 2016-08-26 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
JP6343600B2 (ja) * 2013-02-28 2018-06-13 武田薬品工業株式会社 スルホニルクロライド化合物の製造法
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
KR102084185B1 (ko) * 2013-08-29 2020-03-04 주식회사 대웅제약 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用
UY36547A (es) 2015-02-05 2016-06-01 Bayer Cropscience Ag Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
US10317418B2 (en) 2015-02-24 2019-06-11 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
JP6778680B2 (ja) 2015-07-30 2020-11-04 武田薬品工業株式会社 錠剤
AR105607A1 (es) 2015-08-07 2017-10-18 Bayer Cropscience Ag Derivados heterocíclicos condensados sustituidos por 2-(het)arilo como pesticidas
CN106430006B (zh) * 2016-08-18 2018-06-12 国网湖南省电力公司带电作业中心 配电线路移动式绝缘登高作业装置及方法
CN108203430A (zh) * 2016-12-16 2018-06-26 天地人和生物科技有限公司 一种新型可逆性质子泵抑制剂及其制备方法和用途
MY200542A (en) 2017-07-10 2024-01-02 Takeda Pharmaceuticals Co Preparation comprising vonoprazan
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN113527536B (zh) * 2020-04-21 2024-03-22 杭州德柯医疗科技有限公司 一种含氟多糖高分子化合物及其制备方法
PT4148050T (pt) * 2020-06-17 2025-01-29 Ildong Pharmaceutical Co Ltd Novo inibidor da secreção ácida e sua utilização
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors
AU2022280595B2 (en) 2021-05-26 2024-11-14 Daewoong Pharmaceutical Co., Ltd. Medicine container comprising liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine
CN113620930B (zh) * 2021-07-12 2022-08-16 南京烁慧医药科技有限公司 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用
WO2023113458A1 (en) * 2021-12-15 2023-06-22 Ildong Pharmaceutical Co., Ltd. Novel salt of 1-sulfonyl pyrrole derivative, preparation method thereof and pharmaceutical composition comprising thereof
WO2023113474A1 (ko) * 2021-12-15 2023-06-22 일동제약(주) 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물
KR20230102353A (ko) * 2021-12-30 2023-07-07 주식회사 대웅제약 삼중음성유방암의 예방 또는 치료용 약학적 조성물
KR20260020368A (ko) * 2024-08-02 2026-02-11 일양약품주식회사 4-사이클로프로필 피롤 유도체 및 이의 용도
WO2026135359A1 (ko) * 2024-12-20 2026-06-25 주식회사 유엔에스바이오 4-메틸티오 피롤 유도체

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0259085B1 (en) 1986-08-29 1991-08-21 Pfizer Inc. 2-guanidino-4-arylthiazoles for treatment of peptic ulcers
US5128366A (en) 1990-07-05 1992-07-07 Shinogi & Co., Ltd. Pyrrole derivatives
WO1992004025A1 (en) 1990-08-31 1992-03-19 Warner-Lambert Company Amino acid analogs as cck antagonists
US5331006A (en) * 1990-08-31 1994-07-19 Warner-Lambert Company Amino acid analogs as CCK antagonists
HU219131B (hu) 1991-10-18 2001-02-28 Monsanto Co. Módszer és fungicid készítmény növények torsgombabetegségének gátlására és a hatóanyagok
CN1071924A (zh) 1991-10-29 1993-05-12 纳幕尔杜邦公司 除草的三唑羧酸酰胺
JPH06135961A (ja) 1992-10-23 1994-05-17 Nippon Iyakuhin Kogyo Kk 新規ジフェニルピロリルフラン誘導体
US5286742A (en) * 1992-11-03 1994-02-15 American Cyanamid Company Pyrrole thiocarboxamide insecticidal and acaricidal agents
US5480902A (en) 1993-08-31 1996-01-02 American Cyanamid Company Thienylpyrrole fungicidal agents
JPH08119936A (ja) 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
JPH0930967A (ja) 1995-07-17 1997-02-04 Chugai Pharmaceut Co Ltd 抗潰瘍剤
BR9713465A (pt) 1996-08-28 2000-03-28 Procter & Gamble Inibidores metalotprotease de amina cìclica sibstituìda
CA2275796A1 (en) 1996-12-23 1998-07-02 Donald Joseph Phillip Pinto Nitrogen containing heteroaromatics as factor xa inhibitors
JPH11209344A (ja) 1998-01-26 1999-08-03 Kyowa Hakko Kogyo Co Ltd 含窒素複素環化合物
GB9817548D0 (en) 1998-08-12 1998-10-07 Novartis Ag Organic compounds
DE60020226T2 (de) 1999-03-10 2006-02-02 Shionogi & Co., Ltd. Medizinische zubereitungen mit [2.2.1] und [3.1.1]bicycloskelett die antagonisten für sowohl pgd 2? als auch txa 2? rezeptoren sind
TW575561B (en) 1999-03-25 2004-02-11 Hoffmann La Roche 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
AU3783100A (en) 1999-06-14 2000-12-21 Dow Agrosciences Llc Substituted triazoles, imidazoles and pyrazoles as herbicides
ES2250196T3 (es) 1999-08-26 2006-04-16 Aventis Pharmaceuticals Inc. Aminoiminometil o aminometil dihidrobenzofuranos y benzopiranos sustituidos.
US6911468B2 (en) 2000-05-22 2005-06-28 Takeda Chemical Industries, Ltd. Tyrosine phosphatase inhibitors
US6589978B2 (en) 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
GB0016453D0 (en) 2000-07-04 2000-08-23 Hoffmann La Roche Pyrrole derivatives
US7544690B2 (en) 2001-10-01 2009-06-09 Taisho Pharmaceutical Co., Ltd. MCH receptor antagonists
WO2003040147A1 (en) 2001-11-08 2003-05-15 Pharmacia & Upjohn Company Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
WO2003044011A1 (en) 2001-11-22 2003-05-30 Ciba Specialty Chemicals Holding Inc. Pyrrole synthesis
CA2471754A1 (en) 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Androgen receptor antagonist
WO2003068738A1 (en) 2002-02-11 2003-08-21 Neurocrine Biosciences, Inc. Pyrrole derivatives as ligands of melanocortin receptors
WO2003068740A1 (en) 2002-02-14 2003-08-21 Wyeth Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
TW200306191A (en) 2002-02-22 2003-11-16 Teijin Ltd Pyrrolopyrimidine derivatives
BR0311707A (pt) 2002-06-13 2005-03-15 Du Pont Composto, composição e método de controle de pelo menos uma praga invertebrada
US7186716B2 (en) 2002-08-12 2007-03-06 Sugen, Inc. 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
JP2004315511A (ja) 2003-03-31 2004-11-11 Taisho Pharmaceut Co Ltd Ｍｃｈ受容体アンタゴニスト
US7612064B2 (en) 2003-05-26 2009-11-03 Takeda Pharmaceutical Company Limited Sulfopyrroles
JP5173192B2 (ja) * 2004-09-30 2013-03-27 武田薬品工業株式会社 プロトンポンプ阻害薬
EP1655284A1 (en) 2004-10-26 2006-05-10 Aponetics AG 2-Phenylsulfopyrroles
KR101115857B1 (ko) * 2005-08-30 2012-04-12 다케다 야쿠힌 고교 가부시키가이샤 산 분비 억제제로서 1-헤테로시클릴술포닐, 2-아미노메틸,5-(헤테로-) 아릴 치환된 1-ｈ-피롤 유도체
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
US7994205B2 (en) * 2006-03-31 2011-08-09 Takeda Pharmaceutical Company Limited Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
JP5345140B2 (ja) 2007-09-28 2013-11-20 武田薬品工業株式会社 プロトンポンプ阻害剤としての５員複素環化合物
US20090318429A1 (en) * 2008-04-28 2009-12-24 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
JP5513492B2 (ja) 2008-05-16 2014-06-04 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤
NZ591793A (en) 2008-08-27 2012-11-30 Takeda Pharmaceutical Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds

Also Published As

Publication number Publication date
TWI473798B (zh) 2015-02-21
US8592597B2 (en) 2013-11-26
CN102197033B (zh) 2014-07-16
SMT201300085B (it) 2013-09-06
CA2735162C (en) 2015-06-23
MA32647B1 (fr) 2011-09-01
CR20110169A (es) 2011-05-16
US8993598B2 (en) 2015-03-31
EP2318390B1 (en) 2013-05-01
EA201170384A1 (ru) 2011-10-31
RS52872B (sr) 2013-12-31
CL2011000402A1 (es) 2011-07-29
SI2318390T1 (sl) 2013-08-30
PE20141174A1 (es) 2014-09-19
PL2318390T3 (pl) 2013-09-30
BRPI0917705A2 (pt) 2016-02-16
ZA201101774B (en) 2012-06-27
KR20110071067A (ko) 2011-06-28
MY152008A (en) 2014-08-15
TW201010993A (en) 2010-03-16
ME01598B (me) 2014-09-20
IL211335A (en) 2013-12-31
MX2011001955A (es) 2011-03-29
CA2735162A1 (en) 2010-03-04
AU2009284867B2 (en) 2014-08-28
KR101629181B1 (ko) 2016-06-13
ES2423289T3 (es) 2013-09-19
HK1157756A1 (en) 2012-07-06
UA105185C2 (uk) 2014-04-25
EA019741B1 (ru) 2014-05-30
WO2010024451A1 (en) 2010-03-04
DK2318390T3 (da) 2013-07-08
HRP20130653T1 (en) 2013-08-31
US20100056577A1 (en) 2010-03-04
US20110172275A1 (en) 2011-07-14
EP2318390A1 (en) 2011-05-11
CN102197033A (zh) 2011-09-21
US8969387B2 (en) 2015-03-03
UY32074A (es) 2010-03-26
US20140031393A1 (en) 2014-01-30
CO6321166A2 (es) 2011-09-20
NZ591793A (en) 2012-11-30
AR073136A1 (es) 2010-10-13
PE20110300A1 (es) 2011-06-16
IL211335A0 (en) 2011-04-28
JP2012501296A (ja) 2012-01-19
ECSP11010912A (es) 2011-04-29
JO2871B1 (en) 2015-03-15
AU2009284867A1 (en) 2010-03-04
JP5638515B2 (ja) 2014-12-10
AU2009284867A2 (en) 2011-04-21
GEP20135786B (en) 2013-03-11
PT2318390E (pt) 2013-07-10
DOP2011000061A (es) 2011-04-15

Similar Documents

Publication Publication Date Title
SMT201300085B (it) Composti di pirrolo
CY1117157T1 (el) Υποκατεστημενο παραγωγο ισοκινολινης
CY1124357T1 (el) Προσδιορισμος ανισορροπιας αλληλουχιας νουκλεϊκων οξεων
CY1123308T1 (el) Αναστολεας ινωσης
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
CY1123333T1 (el) Παραγωγα ινδολινονης και διαδικασια για την παραγωγη τους
EA201170096A1 (ru) Замещенные производные пиримидона
CY1116119T1 (el) Παραγωγα ισοξαζολο-πυριδινης
CY1119049T1 (el) Υποκατεστημενα πυρρολιδινο-2-καρβοξαμιδια
CR11021A (es) Derivados de quinolina como fungicidas
CY1110956T1 (el) Παραγωγα πυριδο-πυραζινης χρησιμα ως ζιζανιοκτονες ενωσεις
EA201001124A1 (ru) Производные хинолина и их применение в качестве фунгицидов
CY1118656T1 (el) Παραγωγο πυριδονης
CY1118346T1 (el) Αρυλoαζoλ-2-υλ κυανοαιθυλαμινο ενωσεις, μεθοδος κατασκευης και μεθοδος χρησης αυτων
MY177250A (en) Novel nicotinamide derivative or salt thereof
CY1113812T1 (el) Ετεροκυκλικη ενωση και φαρμακευτικη συνθεση αυτης
CY1115469T1 (el) Παραγωγα βενζοφουρανιου
CY1123154T1 (el) Παραγοντας ενισχυσης της επιδρασης αποκαταστασης μετα απο νευρικη βλαβη που περιλαμβανει ενα παραγωγο αλκυλαιθερα ή ενα αλας αυτου
CY1122477T1 (el) Παραγωγα πυριδο-οξαζινονης ως αναστολεις tnap
BR112014010644A2 (pt) novos derivados de aril-quinolina
MX382878B (es) Estabilizadores de luz de amina bloqueada a base de triazina, piperidina y pirrolidina.
DE502008001409D1 (de) Bisamid-zinkbasen
CY1116875T1 (el) Διϋδροετορφινες και η παρασκευη αυτων
MA32956B1 (fr) Derives de 5-amino-2-(1-hydroxyethyl)-tetrahydropyrane
CY1121626T1 (el) Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου